Investment
Features
FeesSafety
Academy
More
Pluang+

Compare C3.ai Inc (AI) vs Citius Pharmaceuticals Inc (CTXR) Price & Performance

Citius Pharmaceuticals IncTrade

Price performance (Past 24H)

Key statistics

C3.ai Inc vs Citius Pharmaceuticals Inc — how do they compare? C3.ai Inc trades at $10.52 (market cap $1.65B), while Citius Pharmaceuticals Inc trades at $0.73 (market cap $20.01M). The key difference: C3.ai Inc is far larger — about 82.5× Citius Pharmaceuticals Inc's market cap. Which is the better fit depends on your goals.

AICTXR
Market Cap
$1.65B$20.01M
Sector
TechnologyHealth
52-Week High
$19.66$1.82
52-Week Low
$7.76$0.48
Enterprise Value
$1.08B$16.23M

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About C3.ai Inc

C3.ai Inc is an enterprise artificial intelligence company. The company provides software-as-a-service applications that enable customers to rapidly develop, deploy, and operate large-scale Enterprise AI applications across any infrastructure. It provides solutions under three divisions namely, The C3 AI Suite, is a comprehensive application development and runtime environment that is designed to allow customers to rapidly design, develop, and deploy Enterprise AI applications of any type

Read more on AI

About Citius Pharmaceuticals Inc

Citius Pharmaceuticals is a late-stage biopharmaceutical company focused on critical care products. Its pipeline includes anti-infectives and targeted immune therapies for conditions like cutaneous T-cell lymphoma.

Read more on CTXR